Steris (STE) Gains from Investment Securities (2018 - 2026)
Steris (STE) recorded quarterly Gains from Investment Securities of $17.8 million in Q1 2026, up 247.11% quarter-over-quarter from -$12.1 million in Q4 2025, and up 165.67% on a YoY basis from $6.7 million in Q1 2025.
Steris (STE) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Steris' Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $17.8 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 165.67% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $5.6 million (up 51.35% YoY), while the FY2026 annual figure was $5.6 million, up 51.35% from the prior year.
- Gains from Investment Securities was $17.8 million for Q1 2026 at Steris, up from -$12.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $25.5 million in Q1 2023 to a low of -$26.0 million in Q1 2024.
- Historically, Gains from Investment Securities has averaged -$469062.5 across 5 years, with a median of -$116000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities soared 253.18% in 2023, then sank 3933.33% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $8.2 million in 2022, then plunged by 101.61% to -$132000.0 in 2023, then slumped by 127.27% to -$300000.0 in 2024, then tumbled by 3933.33% to -$12.1 million in 2025, then soared by 247.11% to $17.8 million in 2026.
- The last three Gains from Investment Securities figures came in at $17.8 million (Q1 2026), -$12.1 million (Q4 2025), and -$100000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.80 Mn |
| Mar 31, 2026 | 17.80 Mn |
| Dec 31, 2025 | -12.10 Mn |
| Dec 31, 2025 | -12.10 Mn |
| Sep 30, 2025 | -100,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Mar 31, 2025 | 6.70 Mn |
| Mar 31, 2025 | 6.70 Mn |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -500,000.00 |
| Sep 30, 2024 | -500,000.00 |
| Jun 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -25.97 Mn |
| Mar 31, 2024 | -25.97 Mn |
| Dec 31, 2023 | -132,000.00 |
| Dec 31, 2023 | -132,000.00 |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |